THE NEPHROTOXICITY OF CONCURRENT USE OF ENALAPRIL AND GENTAMICIN IN RATS
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i9.26853Keywords:
Nephrotoxicity, Concurrent, Enalapril, GentamicinAbstract
Objective: The present study was aimed to assess the concurrent administration of Enalapril (ENAL) and Gentamicin (GM) in the kidney of rats.
Methods: Sixty male Sprague Dawley rats were divided into 4 main groups (n=15) according to the administered dose. Each main group was further subdivided into three subgroups according to the day of sacrificing (n=5). Group (C) was administered daily with normal saline as control, Group (E) was treated with oral ENAL (2 mg/kg/day), Group (G) was treated with GM (75 mg/kg/day), and Group (EG) was treated ENAL (2 mg/kg/day) and GM (75 mg/kg/day). The handling of the experiment persisted daily for 15 days, and the investigational examination carried out on days 5, 10, and 15.
Results: The result showed that GM nephrotoxicity augmented with the period of the experimental study, there was rising in the levels of serum creatinine and blood urea nitrogen on the 10th day and persisted in rising significantly during the period on the 15th day of the experiment. Administration of ENAL showed no significant alteration from those of controls. While the concurrent administration of ENAL and GM showed that ENAL gradually increased GM nephrotoxicity, these physiological retrogressions were accompanied with intensive renal histopathological deteriorations.
Conclusion: The present study has revealed that the concurrent administration of ENAL enormously aggravated the functional and histological nephrotoxicity of GM in rats.
Downloads
References
Karra G, Ramarao N, Sindhu B, Rao UV. Nephroprotective, nephrocurative activity of mimosa pudica root against gentamicin-induced nephrotoxicity. Int J Pharm Pharm Sci 2015;7:173-7.
Moulds RF, Jeyasingham MS. Gentamicin: A great way to start. Aust Prescr 2010;33:134-5.
Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Di Paola R, Britti D, et al. A role for superoxide in gentamicin-mediated nephropathy in rats. Eur J Pharmacol 2002;450:67-76.
Kim SY, Moon A. Drug-induced nephrotoxicity and its biomarkers. Biomol Ther (Seoul) 2012;20:268-72.
Kalayarasan S, Prabhu PN, Sriram N, Manikandan R, Arumugam M, Sudhandiran G, et al. Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of nrf2 against gentamicin-induced nephrotoxicity in wistar rats. Eur J Pharmacol 2009;606:162-71.
Al-Attiyah ZM, Al-Ani IM, Abdul-Kareem HN, Matlop EI. The Effects of angiotensin-converting-enzyme inhibitor (Captopril) on gentamicin nephrotoxicity in rats. J Med Health Sci 2013;2:80-7.
Silan C, Uzun O, Comunoğlu NU, Gokçen S, Bedirhan S, Cengiz M, et al. Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of resveratrol. Biol Pharm Bull 2007;30:79-83.
Marbut MM, Rajab HK, Al-Mahmood SM. Significance of palpitation among hypertensive patients receiving captoprill. Med J Tikrit 2009;15:32-7.
Makmor-Bakry M, Hamdan N. Effect of angiotensin converting enzyme inhibitors and angiotensin-II receptor blockers on proteinuria of hypertensive patients in standard care practice. Int J Pharm Pharm Sci 2015;7:40-3.
Bhardwaj S, Balgir PP, Goel RK. Pharmacogenomics and personalized management of hypertension. J Critcal Rev 2015;2:1-6.
Delles C, Jacobi J, John S, Fleischmann I, Schmieder RE. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension1. Kidney Int 2002;61:1462-8.
Francischetti A, Ono H, Frohlich ED. Renoprotective effects of felodipine and/or enalapril in spontaneously hypertensive rats with and without L-NAME. Hypertension 1998;31:795-801.
Klotman PE, Boatman JE, Volpp BD, Baker JD, Yarger WE. Captopril enhances aminoglycoside nephrotoxicity in potassium-depleted rats. Kidney Int 1985;28:118-27.
Ali B, Bashir A. Comparative modulating effects of captopril, diltiazem, dietary calcium and pyridoxal-5′-phosphate on gentamicin-induced nephrotoxicity in the rat. Gen Pharmacol 1993;24:1279-83.
Chowdhury MS, Saha SK, Eva EO, Sarker MM. A study on the effect of captopril on gentamicin induced nephrotoxicity in rats. Mymensingh Med J 2018;27:57-67.
Walker PD, Barri Y, Shah SV. Oxidant mechanisms in gentamicin nephrotoxicity. Ren Fail 1999;21:433-42.
Patel Manali B, Deshpande S, Shah G. Evaluation of efficacy of vitamin E and N-acetyl cysteine in gentamicin-induced nephrotoxicity in rats. Ren Fail 2011;33:341-7.
Hayashi T, Watanabe Y, Kumano K, Kitayama R, Yasuda T, Saikawa I, et al. Protective effect of piperacillin against nephrotoxicity of cephaloridine and gentamicin in animals. Antimicrob Agents Chemother 1988;32:912-8.
Kumar KV, Naidu M, Shifow AA, Ratnakar K. Probucol protects against gentamicin-induced nephrotoxicity in rats. Indian J Pharmacol 2000;32:108-13.
Nakahama H, Fukuhara Y, Orita Y, Yamauchi A, Takama T, Kamada T, et al. Furosemide accelerates gentamicin accumulation in cultured renal cells (LLC-PK1 cells). Nephron 1989;53:138-41.
Rankin LI, Luft FC, Yum MN, Sloan RS, Dinwiddie CB Jr., Isaacs LL, et al. Comparative nephrotoxicity of SCH 21420 and amikacin in rats. Antimicrob Agents Chemother 1979;16:491-4.
Dellinger P, Murphy T, Pinn V, Barza M, Weinstein L. Protective effect of cephalothin against gentamicin-induced nephrotoxicity in rats. Antimicrob Agents Chemother 1976;9:172-8.
Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R, et al. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 1995;39:650-5.
Dahl A, Rasmussen RV, Bundgaard H, Hassager C, Bruun LE, Lauridsen TK, et al. Enterococcus faecalis infective endocarditis: A pilot study on the relationship between duration of gentamicin treatment and outcome. Circulation 2013;127:1810-17.
Mandell GL, Bennett JE, Dolin R, Schwartz DA. Principles and practice of infectious disease. Arch Pathol Lab Med 1997;121:908.
Smetana S, Khalef S, Kopolovic G, Bar-Khayim Y, Birk Y, Kacew S, et al. Effect of interaction between gentamicin and pyridoxal-5- phosphate on functional and metabolic parameters in kidneys of female sprague-dawley rats. Ren Fail 1992;14:147-53.
Al-Attiyah ZA. The Concomitant Effect of Gentamicin and Angiotensin-converting-Enzyme Inhibitors (Captopril) on the Renal Structure and Function. M.Sc. Thesis, Al-Mustansiriah University, Baghdad, Iraq; 1996.
Maldonado PD, Barrera D, Medina-Campos ON, Hernández-Pando R, Ibarra-Rubio ME, Pedraza-Chaverrà J, et al. Aged garlic extract attenuates gentamicin induced renal damage and oxidative stress in rats. Life Sci 2003;73:2543-56.
Yanagida C, Ito K, Komiya I, Horie T. Protective effect of fosfomycin on gentamicin-induced lipid peroxidation of rat renal tissue. Chem Biol Interact 2004;148:139-47.
Abdel-Raheem IT, El-Sherbiny GA, Taye A. Green tea ameliorates renal oxidative damage induced by gentamicin in rats. Pak J Pharm Sci 2010;23:21-8.
Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet 2001;357:911-6.
Morin JP, Thomas N, Toutain H, Borghi H, Fillastre JP. Modulation of gentamicin nephrotoxicity by chronic inhibition of angiotensin-I-converting enzyme in rat. Arch Toxicol 1989;63:47-53.
Luft FC, Aronoff GR, Evan AP, Connors BA, Weinberger MH, Kleit SA, et al. The renin-angiotensin system in aminoglycoside-induced acute renal failure. J Pharmacol Exp Ther 1982;220:433-9.
Hirth-Dietrich C, Stasch JP, Ganten D, Luft FC. Renal effects of captopril and nitrendipine in transgenic rats with an extra renin gene. Hypertension 1994;23:626-31.
Patzer L. Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol 2008;23:2159-73.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
